Total Payments
$356,960
2024 Payments
$29,947
Companies
91
Transactions
2,567
Medicare Patients
4,012
Medicare Billing
$414,160
Payment Breakdown by Category
Other$283,219 (79.3%)
Food & Beverage$42,811 (12.0%)
Consulting$26,338 (7.4%)
Travel$3,946 (1.1%)
Education$622.91 (0.2%)
Gifts$22.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $283,219 | 172 | 79.3% |
| Food and Beverage | $42,811 | 2,308 | 12.0% |
| Consulting Fee | $26,338 | 13 | 7.4% |
| Travel and Lodging | $3,946 | 61 | 1.1% |
| Education | $622.91 | 12 | 0.2% |
| Gift | $22.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $92,257 | 241 | $0 (2024) |
| GENZYME CORPORATION | $63,446 | 130 | $0 (2023) |
| Amgen Inc. | $52,403 | 146 | $0 (2024) |
| ABBVIE INC. | $46,459 | 193 | $0 (2024) |
| Allergan, Inc. | $26,411 | 72 | $0 (2022) |
| Acorda Therapeutics, Inc | $23,252 | 48 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $11,797 | 32 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $10,021 | 35 | $0 (2022) |
| SK Life Science, Inc. | $3,218 | 99 | $0 (2024) |
| UCB, Inc. | $3,081 | 108 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,947 | 350 | Teva Pharmaceuticals USA, Inc. ($12,581) |
| 2023 | $25,155 | 351 | AbbVie Inc. ($10,454) |
| 2022 | $54,523 | 384 | ABBVIE INC. ($16,111) |
| 2021 | $49,826 | 300 | Amgen Inc. ($19,613) |
| 2020 | $43,308 | 294 | Allergan, Inc. ($25,409) |
| 2019 | $47,103 | 314 | Teva Pharmaceuticals USA, Inc. ($13,059) |
| 2018 | $55,633 | 288 | GENZYME CORPORATION ($30,421) |
| 2017 | $51,465 | 286 | GENZYME CORPORATION ($20,937) |
All Payment Transactions
2,567 individual payment records from CMS Open Payments — Page 1 of 103
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: PAIN | ||||||
| 12/23/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Immunology | ||||||
| 12/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PAIN | ||||||
| 12/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Rare Disease | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: Neurology | ||||||
| 12/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Neurology | ||||||
| 11/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Neuropsychiatry | ||||||
| 11/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Immunology | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Enspryng (Biological) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 966 | 1,167 | $223,565 | $97,830 |
| 2022 | 8 | 917 | 1,117 | $205,938 | $91,945 |
| 2021 | 12 | 1,059 | 1,354 | $215,122 | $124,130 |
| 2020 | 12 | 1,070 | 5,244 | $220,209 | $100,253 |
Total Patients
4,012
Total Services
8,882
Medicare Billing
$414,160
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 674 | $126,712 | $54,276 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 154 | 154 | $38,038 | $17,194 | 45.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 87 | 91 | $26,754 | $10,784 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 129 | $17,157 | $7,540 | 43.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 44 | $6,600 | $4,010 | 60.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,990 | $1,900 | 47.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 27 | 28 | $2,380 | $1,190 | 50.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 31 | 32 | $1,934 | $937.13 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 532 | 704 | $128,953 | $57,996 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 147 | 147 | $36,154 | $15,381 | 42.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 55 | $16,170 | $7,591 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 134 | $17,282 | $7,207 | 41.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 22 | $2,310 | $1,215 | 52.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 14 | $2,100 | $1,110 | 52.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 18 | 20 | $1,700 | $836.99 | 49.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 21 | 21 | $1,269 | $609.18 | 48.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 481 | 631 | $97,904 | $59,814 | 61.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 144 | 144 | $34,853 | $18,239 | 52.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 190 | $20,140 | $11,966 | 59.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 59 | 62 | $18,228 | $9,921 | 54.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 168 | $17,640 | $9,624 | 54.6% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2021 | 30 | 32 | $10,080 | $5,469 | 54.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 26 | $5,434 | $3,384 | 62.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 17 | $2,550 | $1,397 | 54.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 16 | $2,464 | $1,368 | 55.5% |
About Dr. Andrew Stalker, MD
Dr. Andrew Stalker, MD is a Sleep Medicine healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831136704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Stalker, MD has received a total of $356,960 in payments from pharmaceutical and medical device companies, with $29,947 received in 2024. These payments were reported across 2,567 transactions from 91 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($283,219).
As a Medicare-enrolled provider, Stalker has provided services to 4,012 Medicare beneficiaries, totaling 8,882 services with total Medicare billing of $414,160. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Neurology
- Location Canton, OH
- Active Since 06/01/2006
- Last Updated 06/04/2021
- Taxonomy Code 2084S0012X
- Entity Type Individual
- NPI Number 1831136704
Products in Payments
- AUSTEDO (Drug) $68,003
- UBRELVY (Drug) $59,737
- AUBAGIO (Drug) $59,408
- Aimovig (Biological) $52,375
- NURTEC ODT (Drug) $22,152
- Austedo XR (Drug) $18,169
- AMPYRA (Drug) $13,038
- QULIPTA (Drug) $12,085
- INBRIJA (Drug) $9,664
- SD809-HD (Drug) $3,869
- XCOPRI (Drug) $1,800
- Briviact (Drug) $1,657
- ONZETRA Xsail (Drug) $1,583
- LEMTRADA (Drug) $1,478
- NUEDEXTA (Drug) $1,134
- ZEPOSIA (Drug) $1,070
- Vimpat (Drug) $984.96
- APTIOM (Drug) $955.19
- NUPLAZID (Drug) $941.90
- INGREZZA (Drug) $873.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.